You are here

SARC021

Completed
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Type of Sarcoma: 
Locally advanced or metastatic soft tissue sarcoma
Drug: 
TH-302 combined with doxorubicin vs. doxorubicin alone
Accrual Status: 
Completed
Overall Study Principal Investigator: 
William Tap, MD
Memorial Sloan-Kettering Cancer Center

For more information about this trial and open sites: